Donna Milne Selected Research

dimyristoylphosphatidylinositol

1/2018

Exploring Knowledge, Attitudes, and Practice Associated With Meditation Among Patients With Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Donna Milne Research Topics

Disease

10	Melanoma (Melanoma, Malignant) 01/2021 - 12/2017
4	Neoplasms (Cancer) 01/2021 - 05/2012
3	Fatigue 03/2020 - 01/2019
1	Disease Progression 05/2020

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 01/2021 - 08/2019
2	IpilimumabIBA 05/2020 - 01/2020
2	Monoclonal AntibodiesIBA 05/2020 - 12/2017
2	pembrolizumabIBA 01/2020 - 11/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2020
1	NivolumabIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2019
1	dimyristoylphosphatidylinositolIBA 01/2018
1	AntibodiesIBA 12/2017

Therapy/Procedure

7	Immunotherapy 01/2021 - 01/2019
2	Therapeutics 01/2021 - 09/2020
2	Radiotherapy 01/2019 - 05/2012
2	Palliative Care (Palliative Therapy) 12/2017 - 04/2013
1	Drug Therapy (Chemotherapy) 01/2019
1	Meditation 01/2018